Investor Relations

Corporate Overview

Shuttle Pharmaceuticals (Nasdaq: SHPH) is a clinical-stage pharmaceutical company leveraging our proprietary technology to develop novel therapies that are designed to cure cancer. Led by a best-in-class management team with significant experience in cancer treatment, we are developing a pipeline of revolutionary radiation sensitizers and immunotherapy assisting product candidates.

Latest News

Recent Presentation

Recent Events

Featured Videos

Investor Contact Information


Shuttle Pharmaceuticals
401 Professional Drive, Suite 260
Gaithersburg, MD 20879
Phone: 240-403-4212


Investor Relations

Lytham Partners, LLC
Robert Blum
Phone: 602-889-9700


Transfer Agent

Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179


Skip to content